Travel Vaccines Market Size, Trends, Analysis, and Outlook By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines), by Region, Country, Segment, and Companies, 2024-2030
The global Travel Vaccines market size is poised to register 9.79% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Travel Vaccines market By Disease (Influenza, Diptheria, Hepatitis, Typhoid, Others), By End-User (Adult vaccines, Pediatric vaccines).
The future of travel vaccines is influenced by several key trends shaping the landscape of travel medicine and global health. With increasing globalization and mobility, there is a growing demand for travel vaccines to prevent infectious diseases endemic to specific destinations and regions. Technological advancements in vaccine development and production, including novel delivery platforms and adjuvant systems, are enabling the development of safer and more efficacious travel vaccines with enhanced immunogenicity and durability. Furthermore, the emergence of new infectious disease threats, such as Zika virus and dengue fever, highlights the need for continuous surveillance and rapid vaccine response strategies to address evolving travel-related health risks. Moreover, the growing trend of medical tourism and international travel for leisure and business purposes underscores the importance of pre-travel vaccination counseling and services in promoting traveler safety and public health..
Travel Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Travel Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Travel Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Travel Vaccines industry.
Key market trends defining the global Travel Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Travel Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Travel Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Travel Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Travel Vaccines industry
Leading Travel Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Travel Vaccines companies.
Travel Vaccines Market Study- Strategic Analysis Review
The Travel Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Travel Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Travel Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Travel Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Travel Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Travel Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Travel Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Travel Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Travel Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Travel Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Travel Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Travel Vaccines in Asia Pacific. In particular, China, India, and South East Asian Travel Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Travel Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Travel Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Travel Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Travel Vaccines.
Travel Vaccines Market Company Profiles
The global Travel Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Altimmune Inc, AstraZeneca Plc, Bavarian Nordic AS, CSL Ltd, Dynavax Technologies Corp, Emergent BioSolutions Inc, GlaxoSmithKline Plc, KM Biologics Co. Ltd, LG Chem Ltd, Merck and Co. Inc, Novartis AG, Pfizer Inc, Sanofi SA, Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, SK Chemicals Co. Ltd, Takeda Pharmaceutical Co. Ltd, Valneva SE.
Recent Travel Vaccines Market Developments
The global Travel Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Travel Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
Geographical Segmentation:
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
Formats Available: Excel, PDF, and PPT
The future of travel vaccines is influenced by several key trends shaping the landscape of travel medicine and global health. With increasing globalization and mobility, there is a growing demand for travel vaccines to prevent infectious diseases endemic to specific destinations and regions. Technological advancements in vaccine development and production, including novel delivery platforms and adjuvant systems, are enabling the development of safer and more efficacious travel vaccines with enhanced immunogenicity and durability. Furthermore, the emergence of new infectious disease threats, such as Zika virus and dengue fever, highlights the need for continuous surveillance and rapid vaccine response strategies to address evolving travel-related health risks. Moreover, the growing trend of medical tourism and international travel for leisure and business purposes underscores the importance of pre-travel vaccination counseling and services in promoting traveler safety and public health..
Travel Vaccines Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Travel Vaccines market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Travel Vaccines survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Travel Vaccines industry.
Key market trends defining the global Travel Vaccines demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Travel Vaccines Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Travel Vaccines industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Travel Vaccines companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Travel Vaccines industry
Leading Travel Vaccines companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Travel Vaccines companies.
Travel Vaccines Market Study- Strategic Analysis Review
The Travel Vaccines market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Travel Vaccines industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Travel Vaccines Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Travel Vaccines Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Travel Vaccines market segments. Similarly, Strong end-user demand is encouraging Canadian Travel Vaccines companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Travel Vaccines market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Travel Vaccines Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Travel Vaccines industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Travel Vaccines market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Travel Vaccines Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Travel Vaccines in Asia Pacific. In particular, China, India, and South East Asian Travel Vaccines markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Travel Vaccines Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Travel Vaccines Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Travel Vaccines market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Travel Vaccines.
Travel Vaccines Market Company Profiles
The global Travel Vaccines market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott Laboratories, Altimmune Inc, AstraZeneca Plc, Bavarian Nordic AS, CSL Ltd, Dynavax Technologies Corp, Emergent BioSolutions Inc, GlaxoSmithKline Plc, KM Biologics Co. Ltd, LG Chem Ltd, Merck and Co. Inc, Novartis AG, Pfizer Inc, Sanofi SA, Serum Institute of India Pvt. Ltd, Shenzhen Kangtai Biological Products Co. Ltd, SK Chemicals Co. Ltd, Takeda Pharmaceutical Co. Ltd, Valneva SE.
Recent Travel Vaccines Market Developments
The global Travel Vaccines market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Travel Vaccines Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Travel Vaccines Market Overview and Key Findings, 2024
1.2 Travel Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Travel Vaccines Market Growth Opportunities to 2030
1.4 Key Travel Vaccines Market Trends and Challenges
1.4.1 Travel Vaccines Market Drivers and Trends
1.4.2 Travel Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Travel Vaccines Companies
2. TRAVEL VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Travel Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Travel Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. TRAVEL VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. TRAVEL VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Travel Vaccines Market, 2025
5.2 Asia Pacific Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Travel Vaccines Market, 2025
5.5 Europe Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Travel Vaccines Market, 2025
5.8 North America Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Travel Vaccines Market, 2025
5.11 South America Pacific Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Travel Vaccines Market, 2025
5.14 Middle East Africa Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Travel Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Travel Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Travel Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Travel Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Travel Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Travel Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Travel Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Travel Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Travel Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Travel Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Travel Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Travel Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Travel Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Travel Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Travel Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Travel Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Travel Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Travel Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Travel Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Travel Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Travel Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Travel Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Travel Vaccines Industry Drivers and Opportunities
7. TRAVEL VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. TRAVEL VACCINES COMPANY PROFILES
8.1 Profiles of Leading Travel Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Travel Vaccines Market Overview and Key Findings, 2024
1.2 Travel Vaccines Market Size and Growth Outlook, 2021- 2030
1.3 Travel Vaccines Market Growth Opportunities to 2030
1.4 Key Travel Vaccines Market Trends and Challenges
1.4.1 Travel Vaccines Market Drivers and Trends
1.4.2 Travel Vaccines Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Travel Vaccines Companies
2. TRAVEL VACCINES MARKET SIZE OUTLOOK TO 2030
2.1 Travel Vaccines Market Size Outlook, USD Million, 2021- 2030
2.2 Travel Vaccines Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. TRAVEL VACCINES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. TRAVEL VACCINES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Type
Stationary 3D and 4D Ultrasound Devices
Portable 3D and 4D Ultrasound Devices
By Display
Color Ultrasound
B/W Ultrasound
By Portability
Trolley or Cart-Based Ultrasound Systems
Compact/Handheld Ultrasound Systems
Point-of-Pare (PoC) Ultrasound Systems
By Application
Radiology or General Imaging
Obstetrics or Gynecology
Cardiology
Urology
Vascular
Orthopedic and Musculoskeletal
Pain Management
Others
By End-User
Hospitals
Surgical Centers and Diagnostic Centers
Maternity Centers
Ambulatory Care Centers
Research and Academia
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Travel Vaccines Market, 2025
5.2 Asia Pacific Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Travel Vaccines Market, 2025
5.5 Europe Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.6 Europe Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Travel Vaccines Market, 2025
5.8 North America Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.9 North America Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Travel Vaccines Market, 2025
5.11 South America Pacific Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.12 South America Travel Vaccines Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Travel Vaccines Market, 2025
5.14 Middle East Africa Travel Vaccines Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Travel Vaccines Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Travel Vaccines Market Size Outlook and Revenue Growth Forecasts
6.2 US Travel Vaccines Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Travel Vaccines Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Travel Vaccines Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Travel Vaccines Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Travel Vaccines Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Travel Vaccines Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Travel Vaccines Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Travel Vaccines Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Travel Vaccines Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Travel Vaccines Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Travel Vaccines Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Travel Vaccines Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Travel Vaccines Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Travel Vaccines Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Travel Vaccines Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Travel Vaccines Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Travel Vaccines Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Travel Vaccines Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Travel Vaccines Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Travel Vaccines Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Travel Vaccines Industry Drivers and Opportunities
7. TRAVEL VACCINES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. TRAVEL VACCINES COMPANY PROFILES
8.1 Profiles of Leading Travel Vaccines Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott Laboratories
Altimmune Inc
AstraZeneca Plc
Bavarian Nordic AS
CSL Ltd
Dynavax Technologies Corp
Emergent BioSolutions Inc
GlaxoSmithKline Plc
KM Biologics Co. Ltd
LG Chem Ltd
Merck and Co. Inc
Novartis AG
Pfizer Inc
Sanofi SA
Serum Institute of India Pvt. Ltd
Shenzhen Kangtai Biological Products Co. Ltd
SK Chemicals Co. Ltd
Takeda Pharmaceutical Co. Ltd
Valneva SE
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
